Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000418029 | SCV000532782 | uncertain significance | not provided | 2020-05-18 | criteria provided, single submitter | clinical testing | Not observed at a significant frequency in large population cohorts (Lek et al., 2016); In silico analysis suggests this variant may impact gene splicing. In the absence of RNA/functional studies, the actual effect of this sequence change is unknown.; Has not been previously published as pathogenic or benign to our knowledge |
Labcorp Genetics |
RCV001861623 | SCV002232649 | likely benign | Alpha thalassemia-X-linked intellectual disability syndrome | 2024-02-23 | criteria provided, single submitter | clinical testing | |
Clinical Genomics Laboratory, |
RCV001861623 | SCV004177097 | uncertain significance | Alpha thalassemia-X-linked intellectual disability syndrome | 2023-10-20 | criteria provided, single submitter | clinical testing | The ATRX c.1478A>G (p.His493Arg) variant has not been reported in the medical literature to our knowledge. This variant is only observed on 1/183,019 total alleles in the general population (gnomAD v.2.1.1), indicating it is not a common variant. Computational predictors are uncertain/conflicting as to the impact of this variant on ATRX protein function. This variant has been submitted to ClinVar as both a variant of uncertain significance and likely benign; one submitter each (variation ID: 390054). Due to limited information, and based on ACMG/AMP guidelines for variant interpretation (Richards S et al., PMID: 25741868), the clinical significance of this variant is uncertain at this time. |